本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CRISPR Therapeutics AG

62.32
-0.6200-0.99%
盘后63.150.8300+1.33%19:45 EDT
成交量:523.43万
成交额:3.29亿
市值:56.68亿
市盈率:-11.45
高:64.18
开:63.18
低:62.27
收:62.94
52周最高:71.13
52周最低:30.04
股本:9,095.04万
流通股本:9,053.30万
量比:1.80
换手率:5.78%
股息:- -
股息率:- -
每股收益(TTM):-5.4437
每股收益(LYR):-4.3416
净资产收益率:-25.34%
总资产收益率:-13.05%
市净率:3.31
市盈率(LYR):-14.35

数据加载中...

2019/08/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/29

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/07/29

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/07/29

重要事件披露

Current report, items 2.02 and 9.01
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/28

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/26

重要事件披露

Current report, item 8.01
2019/06/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/13

重要事件披露

Current report, items 5.02, 5.03, 5.07, and 9.01
2019/06/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/07

超过5%披露

[Amend] General statement of acquisition of beneficial ownership